CMS Recognizes New Compendium For Covering Cancer Drugs

June 6, 2008 – The Medicare program will recognize a new source of information, the National Comprehensive Cancer Network (NCCN) Drugs and Biologics Compendium, for determining which drugs may be covered under Medicare Part B to treat cancer patients.

The Centers for Medicare and Medicaid Services (CMS) also said it will cease using the American Medical Association Drug Evaluations (AMA-DE) compendium, as the compendium has not been updated since 1995.

Please see the CMS Web site for more information.